Literature DB >> 10489916

Essential fatty acid deficiencies in patients with chronic liver disease are not reversed by short-term intravenous lipid supplementation.

D R Duerksen1, V Nehra, J D Palombo, A Ahmad, B R Bistrian.   

Abstract

The purpose of this study was to determine the plasma triglyceride and phospholipid fatty acid (FA) composition of severely malnourished patients with chronic liver disease and to examine the effects of parenteral nutrition with a total nutrient admixture (TNA) on these profiles. Nine consecutive patients with end-stage chronic liver disease were compared with 35 patients admitted for elective surgery of upper gastrointestinal malignancy. Baseline laboratory values and the FA profiles of the plasma triglyceride and phospholipids were analyzed. FA profiles were also performed after infusion of a TNA including 33+/-7 g of lipid/24 hr for 7.9+/-4 days in the patients with chronic liver disease. Compared with control patients, the plasma phospholipid fatty acid analysis results (relative mole percentage) of patients with chronic liver disease were significantly lower in the two essential FA, linoleic acid (15.4+/-3.4% vs. 20.8+/-2.9%, P<0.001) and alpha-linolenic acid (0.02+/-0.05% vs. 0.08+/-0.10%, P<0.001). Similar changes were demonstrated in the FA composition of the triglyceride fraction. Short-term infusion of intravenous lipid resulted in a significant increase in linoleic acid in the triglyceride fraction (9.9+/-2.8% before supplementation vs. 20.7+/-9.4% after supplementation, P<0.01) and a decrease in oleic acid (38.7+/-5.2% before supplementation vs. 29.3+/-7.5 after supplementation, P<0.01). In conclusion, acute and chronic deficiencies of essential FA occurs in patients with chronic liver disease. The clinical significance of these deficiencies is unknown, but they potentially may impact on eicosanoid metabolism. Short-term supplementation with modest amounts of intravenous lipid has only a minimal effect on normalization of longer-chain fatty acids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489916     DOI: 10.1023/a:1026683214681

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  Disordered energy and protein metabolism in liver disease.

Authors:  A J McCullough; A S Tavill
Journal:  Semin Liver Dis       Date:  1991-11       Impact factor: 6.115

2.  Energy metabolism in patients with acute and chronic liver disease.

Authors:  B Schneeweiss; W Graninger; P Ferenci; S Eichinger; G Grimm; B Schneider; A N Laggner; K Lenz; G Kleinberger
Journal:  Hepatology       Date:  1990-03       Impact factor: 17.425

3.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

4.  Intralipid clearance and lipoprotein pattern in men with advanced alcoholic liver cirrhosis.

Authors:  S Rössner; C Johansson; G Walldius; A Aly
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

5.  Is there a role for the liver in the control of food intake?

Authors:  D Novin; K Robinson; L A Culbreth; M G Tordoff
Journal:  Am J Clin Nutr       Date:  1985-11       Impact factor: 7.045

Review 6.  Is total parenteral nutrition immunosuppressive?

Authors:  J J Pomposelli; B R Bistrian
Journal:  New Horiz       Date:  1994-05

7.  Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids.

Authors:  R T Holman; C E Adams; R A Nelson; S J Grater; J A Jaskiewicz; S B Johnson; J W Erdman
Journal:  J Nutr       Date:  1995-04       Impact factor: 4.798

8.  High lipid parenteral nutrition improves portasystemic encephalopathy.

Authors:  M J Glynn; J Powell-Tuck; D A Reaveley; I M Murray-Lyon
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Sep-Oct       Impact factor: 4.016

9.  Endotoxin challenge after menhaden oil diet: effects on survival of guinea pigs.

Authors:  E A Mascioli; Y Iwasa; S Trimbo; L Leader; B R Bistrian; G L Blackburn
Journal:  Am J Clin Nutr       Date:  1989-02       Impact factor: 7.045

10.  Ascites increases the resting energy expenditure in liver cirrhosis.

Authors:  C Dolz; J M Raurich; J Ibáñez; A Obrador; P Marsé; J Gayá
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  1 in total

1.  Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study.

Authors:  Sassan Pazirandeh; Pei-Ra Ling; Mario Ollero; Fredric Gordon; David L Burns; Bruce R Bistrian
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Nov-Dec       Impact factor: 4.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.